Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2007Lack of influence of CYP2D6 genotype on the clearance of (R)- (S)- and racemic-methadonColler, J.; Joergensen, C.; Foster, D.; James, H.; Gillis, D.; Christrup, L.; Somogyi, A.
2018CYP3A5*3 and ABCB1 61A>G significantly influence dose-adjusted trough blood tacrolimus concentrations in the first three months post-kidney transplantationHu, R.; Barratt, D.; Coller, J.; Sallustio, B.; Somogyi, A.
2013Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsiesNoll, B.; Coller, J.; Somogyi, A.; Morris, R.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
2008Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexilineDavies, B.; Herbert, M.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B.
1999Flunitrazepam oxidative metabolism in human liver microsomes: involvement of CYP2C19 and CYP3A4Coller, J.; Somogyi, A.; Bochner, F.
2006ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individualsColler, J.; Barratt, D.; Dahlen, K.; Loennechen, M.; Somogyi, A.
2004Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexilineDavies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.; Horowitz, J.; Morris, R.; Sallustio, B.
1999Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.Coller, J.; Somogyi, A.; Bochner, F.